The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticlesFull Access

Uses of Research Evidence by State Legislators Who Prioritize Behavioral Health Issues

Abstract

Objective:

Disseminating behavioral health (BH) research to elected policy makers is a priority, but little is known about how they use and seek research evidence. This exploratory study aimed to identify research dissemination preferences and research-seeking practices of legislators who prioritize BH issues and to describe the role of research in determining policy priorities. The study also assessed whether these legislators differ from those who do not prioritize BH issues.

Methods:

A telephone-based survey was conducted with 862 state legislators (response rate, 46%). A validated survey instrument assessed priorities and the factors that determined them, research dissemination preferences, and research-seeking practices. Bivariate analyses were used to characterize and compare the two groups.

Results:

Legislators who prioritized BH issues (N=125) were significantly more likely than those who did not to identify research evidence as a factor that determined policy priorities (odds ratio=1.91, 95% confidence interval=1.25–2.90, p=.002). Those who prioritized BH issues also attributed more importance to ten of 12 features of research, and the difference was significant for four features (unbiased, p=.014; presented in a concise way, p=.044; delivered by someone known or respected, p=.033; and tells a story, p=.030). Those who prioritized BH issues also engaged more often in eight of 11 research-seeking and utilization practices, and a significance difference was found for one (attending research presentations, p=.012).

Conclusions:

Legislators who prioritized BH issues actively sought, had distinct preferences for, and were particularly influenced by research evidence. Testing legislator-focused BH research dissemination strategies is an area for future research.

The purpose of research on mental illness and substance misuse (hereafter referred to as behavioral health [BH] research) is to improve population well-being. Public policy can help achieve this aim by allocating resources for evidence-based interventions and enacting regulations that support the prevention, management, and treatment of BH disorders (13). For BH research to inform policy decisions, however, policy makers must be knowledgeable about the research. Thus disseminating BH research to policy makers has been resoundingly acknowledged as a priority in the United States (410).

Dissemination is defined as the use of tailored strategies and preferred communication channels to spread research evidence among target audiences (11,12). The importance of policy-focused dissemination is apparent in the Substance Abuse and Mental Health Services Administration’s action plan (7), the National Institute of Mental Health’s (NIMH) objective to strengthen the public health impact of NIMH-supported research (8), the National Institute on Drug Abuse’s mission to ensure the rapid and effective dissemination of research results to inform policy (9), and the National Institute on Alcohol Abuse and Alcoholism’s mission of translating and disseminating research findings to policy makers (10).

Dissemination does not occur spontaneously, however, and the “passive” dissemination strategies typically used by researchers (for example, peer-reviewed publications) are generally ineffective at reaching policy makers (1316). Dissemination is most effective when tailored to specific audiences (17), and the field of policy dissemination research has emerged to address this need by generating knowledge about policy makers’ preferences for receiving research evidence (for example, who delivers it and how it is presented) and the practices through which it is used (for example, when and where policy makers seek it) (1820). Few policy dissemination studies have explored BH issues (21), however, and little empirical evidence exists to inform the design of policy-focused BH dissemination strategies.

A recent systematic review of interventions to increase the use of research in BH policy making highlighted the knowledge gap (22). The review identified only nine studies, and, as the authors noted, virtually none involved public policy makers (a policy maker was broadly defined as any decision maker, including program directors and community leaders). These results were consistent with previous reviews that identified few studies focused on how research evidence is used in BH policy making (23,24). Studies have explored uses of research in BH policy making in Canada (25,26), Australia (27,28), and Belgium (29), but they offer limited guidance regarding how to disseminate BH research to U.S. policy makers. Corrigan and Watson (30) extrapolated findings from social psychological research to propose factors (for example, political ideology) that might influence policy makers’ decisions about mental health services. The article, however, primarily drew from studies conducted with student populations, not with actual policy makers. A qualitative study of federal policy makers found that research evidence was important in passing BH parity legislation, but the study did not explore issues related to research dissemination (31).

BH research dissemination has been inadequately investigated among state policy makers. This knowledge gap warrants particular attention because most government authority to address BH issues exists at the state level. State policy makers, for example, determine the types of BH services that are reimbursable through Medicaid—the largest payer for BH services in the country (32,33). Federal legislation has attempted to promote BH insurance parity (34), but state legislation is needed to supplement federal laws and ensure equal coverage (35,36).

Our study addressed a critical gap in the field of BH services research by analyzing survey data collected from state legislators (that is, policy makers elected to the state houses or state senates). The primary aim of this exploratory study was to identify the research dissemination preferences and research-seeking practices of legislators who prioritized BH issues and describe the role research plays in determining their policy priorities. The secondary aim was to assess whether legislators who prioritize BH issues differ from legislators who do not prioritize these issues.

Theoretical Framework

Our decision to focus on legislators who prioritize BH issues was motivated by Kingdon’s (37,38) multiple streams theory of the policy-making process. The theory is founded on the premise that countless issues are constantly competing for policy makers’ attention and that three “streams” determine whether and how issues are addressed: a problem stream, consisting of issues that need to be addressed; a policy stream, consisting of solutions to these issues; and a political stream, consisting of public opinion and the broader sociopolitical environment. When these three streams converge around an issue, a “policy window” opens and “policy entrepreneurs” (that is, people who advocate for a specific issue) can advance their proposals to address it.

Accordingly, our study focused on legislators who perceived BH issues as priorities because these legislators are most likely to act as policy entrepreneurs and advance policies to address BH issues when a policy window opens (39). By producing a better understanding of how this important subgroup of legislators uses research evidence, the study can inform how BH research might be most effectively communicated to them via targeted dissemination strategies. By assessing whether this subgroup of legislators differs from legislators who do not prioritize BH issues, the study can signal whether tailored dissemination strategies are needed or if uniform strategies are sufficient.

Methods

Design, Participants, and Recruitment

We conducted a cross-sectional survey of state legislators. We partnered with the National Conference of State Legislatures to obtain a complete list of state legislators (N=7,525) and generated a random sample of 2,000 legislators who were invited to participate in a telephone-based survey between January and October 2012. Up to ten attempts were made to contact each legislator, 1,719 were successfully contacted, and 862 completed the survey (response rate, 46%). This is considered a good response rate for a legislator population (40). The survey was administered by an independent research firm. The survey was anonymous; answers cannot be traced back to particular respondents. Institutional review board approval was obtained from Washington University in St. Louis.

Measures

We measured legislators’ use of research evidence with an instrument that has been validated with state legislators (16,41,42). Details about the sources of instrument items and reliability coefficients are described elsewhere (16).

Legislators’ prioritization of BH issues.

Whether or not legislators perceived BH issues as policy priorities (yes or no) served as the dependent variable. Two items were used to determine this. First, legislators were prompted with the open-ended question: “Describe one or two policy priorities that are most important to you” (Q1). Legislators were then asked to select “the top three most important health issues for policy action in your state” (Q2) and presented with a list of 19 issues: “mental health,” “prescription drug abuse,” “access to healthcare,” “aging,” “cancer,” “diabetes,” “diet/nutrition,” “heart disease,” “HIV/AIDS,” “infectious diseases,” “injury prevention,” “Medicare/Medicaid,” “obesity,” “physical activity,” “quality of healthcare,” “the environment,” “tobacco use/cessation,” “universal coverage,” and “violence prevention,” in addition to an open-ended “other” option. At least one “other” health issue was named by 77% (N=664) of respondents.

Open-ended responses from Q1 and Q2 were searched for the terms “mental,” “behavioral,” and “psych” to screen for mental health issue prioritization and for “substance,” “drug,” and “alcohol” to screen for substance misuse issue prioritization. Each response was coded as “mental health,” “substance misuse,” “both,” or “neither.’’ A legislator was categorized as perceiving BH issues as priorities if he or she identified a mental health issue, a substance misuse issue, or both in open-ended responses to Q1 or Q2 or selected “mental health” or “prescription drug abuse” in response to Q2.

Factors that determine legislators’ health policy priorities.

As a follow-up to Q2, legislators were asked to select “which two factors most help you determine which health issues you work on” and were presented with a list of seven options.

Legislators’ research dissemination preferences.

Legislators were presented with 12 statements about features of disseminated research and instructed to “rate the level of priority that you attribute to each” on a scale of 1, low priority, to 5, high priority. To assess how perceptions of disseminated research varied according to the source, legislators were also presented with a list of eight sources of disseminated research (for example, universities and the media) and instructed to “rate the reliability” on a scale of 1, very unreliable, to 5, very reliable.

Legislators’ research-seeking and utilization practices.

Legislators were presented with 11 statements about research-seeking and utilization practices. Seven statements focused on where legislators go when seeking research evidence, and four focused on what they do with it. For each statement, legislators were prompted with the statement, “When making policy, how often do you . . .,” and they rated each on a scale of 1, never, to 5, always.

Legislators’ individual characteristics.

We collected information on legislators’ gender, educational attainment, parental status, self-rated health status, number of years served in the state legislature, chamber (house or senate), and political party membership. We also asked legislators whether they identified as liberal, moderate, or conservative on social issues and fiscal issues.

Analysis

Univariate descriptive statistics were produced to characterize the study population, stratified by whether or not the legislator prioritized BH issues. For dichotomous independent variables, Pearson chi-square and Fisher’s exact tests were used to identify associations with BH issue prioritization. Unadjusted odds ratios (ORs) with 95% confidence intervals (CIs) were produced to quantify the magnitude of these associations. For continuous and ordinal independent variables, we conducted two-tailed, independent-sample t tests and Mann-Whitney U tests to compare means between legislators who did and did not prioritize BH issues. Responses of “don’t know” and “refuse to answer” were coded as missing and excluded from analyses. Missing data did not exceed 3% for any variable.

Results

Of the 862 legislators who completed the survey, 125 (15%) identified BH issues as priorities (Table 1). Of these, 60 (48%) identified mental health issues, 57 (46%) identified substance misuse issues, and eight (6%) identified both. There were no significant differences between legislators who identified mental health issues and legislators who identified substance misuse issues. Legislators who prioritized BH issues were not significantly different from those who did not prioritize BH issues in terms of any individual characteristic.

TABLE 1. Characteristics of state legislators in 2012, by whether or not they prioritized behavioral health (BH) issues

CharacteristicAll legislators (N=862)BH policy priority
Yes (N=125)No (N=737)
N%N%N%χ2ap
Gender
 Male62973987853174.92.337
 Female21024272218326.92.337
Education
 High school graduate or less36454314.03.855
 Trade or vocational school1620162b.149
 Some college or college graduate405475443351491.61.203
 Postgraduate degree379446653313443.31.069
Has children
 Yes755881149264190.559.455
 No106121199513
Self-rated health status
 Excellent or very good52961846744563.97.324
 Good249293226217311.2.267
 Fair or poor58797497.02.900
Years in state legislature (M±SD)8629.3±7.29.0±7.9b.516
Chamber
 House648759475.255477.6.35.556
 Senate191223124.816022.4.35.556
Political party
 Democrat379445846.432145.1.07.795
 Republican443516652.837753.0.01.963
 Other1421.8131.8b.706
Position on social issues
 Liberal23527363019929.06.815
 Moderate16519262113920.13.717
 Conservative41848594835951.37.541
Position on fiscal issues
 Liberal86101087611.81.369
 Moderate17420231815121.82.366
 Conservative568669274476672.34.126

adf=1

bFisher’s exact test was used to compare differences between legislators who did and did not prioritize BH issues.

TABLE 1. Characteristics of state legislators in 2012, by whether or not they prioritized behavioral health (BH) issues

Enlarge table

Factors Determining Health Policy Priorities

Legislators who prioritized BH issues were significantly more likely than legislators who did not to select research evidence as one of the two factors that determined health policy priorities (32% versus 20%, OR=1.91, p=.002) (Table 2). Research evidence was the second most frequently cited factor by legislators who prioritized BH issues, whereas it was fifth most frequently cited by legislators who did not prioritize BH issues. Constituents’ needs and opinions was cited as the primary factor that determined health policy priorities by legislators who prioritized BH issues (66%) and by those who did not (68%). Among both groups of legislators, economic issues (N=151, 18%) and interactions with lobbyists (N=62, 7%) were the factors least frequently cited.

TABLE 2. Factors identified by state legislators in 2012 as determining their health policy priorities, by whether or not they prioritized behavioral health (BH) issues

FactoraBH policy priorityORb95% CIp
Yes (N=125)No (N=737)
N%N%
Constituents’ needs and opinions826647468.93.62–1.10.728
Research evidence4032140201.911.25–2.90.002
Legislation proposed by colleagues352822132.85.56–1.30.458
Data impact local area332720830.86.56–1.32.484
Personal interest252016123.85.53–1.36.486
Economic issues221812918.96.58–1.57.855
Interaction with lobbyists1085271.09.54–2.21.805

aEach respondent was limited to selecting two factors.

bThe odds ratios reflect the association between the odds of a legislator identifying BH issues as policy priorities and each factor that determined health policy priorities.

TABLE 2. Factors identified by state legislators in 2012 as determining their health policy priorities, by whether or not they prioritized behavioral health (BH) issues

Enlarge table

Research Dissemination Preferences

In addition to being more influenced by research when determining health policy priorities, legislators who prioritized BH issues were more discerning consumers of research evidence than legislators who did not prioritize BH issues. Legislators who prioritized BH issues gave a higher importance rating than legislators who did not to ten of 12 statements about features of disseminated research (Table 3). Differences were statistically significant for four of these features: unbiased (p=.014); presented in a brief, concise way (p=.044); delivered by a person the legislator knows and respects (p=.033); and telling a story about how a health issue affects constituents (p=.030). The unbiased aspect of research was the factor with the highest rating among legislators who prioritized BH issues, whereas it was tied for fourth among legislators who did not prioritize BH issues. The political feasibility of research received the lowest rating regardless of whether BH issues were identified as priorities.

TABLE 3. Research dissemination preferences of state legislators in 2012, by whether or not they prioritized behavioral health (BH) issues

PreferenceBH policy priorityaMann-dfp
Yes (N=125)No (N=737)
MSDMSDWhitney U
Features of disseminated research
 Unbiased4.54.824.291.0240,095826.014
 Understandably written4.47.824.45.8036,518816.770
 Presented in a brief, concise way4.46.864.33.8643,517834.044
 Available at the time decisions are being made4.43.834.42.8239,539832.778
 Deals with a priority issue for legislative policy action4.39.794.29.8140,088824.158
 Relevant to my constituents4.32.784.19.8540,095826.150
 Provides data on the cost-effectiveness of a policy4.30.864.29.8243,251828.817
 Delivered to me by someone I know or respect4.27.774.07.9138,976830.033
 Tells a story of how a health issue affects my constituents4.20.834.00.9238,375826.030
 Provides policy options4.15.844.07.924,1461826.409
 Supports my position3.311.153.461.1245,959822.179
 Has politically feasible implications3.271.223.411.1843,929810.295
Reliability of sources of disseminated research
 University3.97.8233.87.8641,014825.384
 Constituents3.521.013.45.9141,198825.432
 Other legislators3.41.863.35.7840,369824.251
 Government source3.36.823.24.9240,602823.317
 Caucus leadership3.301.003.15.9838,914818.109
 Industry3.15.923.13.8943,272829.808
 Advocacy groups2.70.842.83.8946,035833.155
 Media2.21.822.16.8642,335829.603

aPossible scores range from 1 to 5, with higher scores indicating higher priority or higher perceived reliability

TABLE 3. Research dissemination preferences of state legislators in 2012, by whether or not they prioritized behavioral health (BH) issues

Enlarge table

Legislators who prioritized BH issues generally perceived research to be more reliable than legislators who did not prioritize BH issues, regardless of the dissemination source (Table 3). Legislators who prioritized BH issues reported a higher reliability rating than legislators who did not prioritize BH issues for seven of eight sources of disseminated research, although none of the differences were significant. Universities were identified as the most reliable source and media as the least reliable source by legislators who did and who did not prioritize BH issues.

Research-Seeking and Utilization Practices

Legislators who prioritized BH issues reported being more active seekers and users of research than legislators who did not prioritize BH issues. The former group engaged in eight of 11 research-seeking and utilization practices more often than those who did not prioritize BH issues (Table 4), although the only significant difference was for the practice of attending seminars or presentations where research was discussed (p=.012). Among all legislators, asking internal legislative research bureaus for information was performed most often and reading or watching popular media stories was performed least often.

TABLE 4. Research-seeking and utilization practices of state legislators in 2012, by whether or not they prioritized behavioral health (BH) issues

PracticeBH policy priorityaMann-dfp
Yes (N=125)No (N=737)
MSDMSDWhitney U
Research seeking
 Ask internal legislative research bureaus for information4.23.944.061.0440,117834.088
 Explore what other states are doing3.721.043.62.9641,383836.182
 Read scientific research reports3.481.043.281.1740,513835.099
 Ask an external legislative research organization for information3.391.143.361.1343,346834.739
 Attend seminars or presentations where research is discussed3.051.152.781.0938,532836.012
 Contact scientific researchers or experts for advice2.941.132.901.1943,142832.715
 Read or watch popular media stories2.771.192.821.1845,820833.470
Research utilization
 Use research to justify a decision4.16.954.11.9141,487831.424
 Talk with colleagues about research on important issues4.151.004.15.9243,378836.702
 Use research presented in committee testimony4.11.924.11.9344,240832.946
 Take the results of a relevant scientific study into account when making a decision3.99.993.97.9242,507832.514

aPossible scores range from 1 to 5, with higher scores indicating greater frequency.

TABLE 4. Research-seeking and utilization practices of state legislators in 2012, by whether or not they prioritized behavioral health (BH) issues

Enlarge table

Discussion

We found that legislators who prioritized BH issues actively sought and were influenced by research evidence—and more so than legislators who did not prioritize BH issues. These results suggest that the legislators who are most likely to act as BH policy entrepreneurs and best positioned to integrate BH research findings into policy designs are particularly receptive to research evidence and have distinct dissemination presences, although the magnitude of these differences was small. Future studies should examine in greater detail how BH research is used in state legislative processes and test the effects of legislator-focused BH research dissemination strategies. Our results offer guidance to structure the design of these strategies.

The finding that legislators who prioritized BH issues reported a significantly higher importance rating for the statement that research “tells a story of how a health issue affects my constituents” suggests that dissemination strategies that combine narrative with local BH data could be effective. Studies have found that narrative approaches to policy dissemination, in which stories about individuals affected by an issue are presented, are often more effective than exclusively data-focused approaches (4345). This is consistent with research finding that people’s perceptions of mental illness improve when they know a person with a diagnosis (46) and Corrigan and Watson’s (30) proposition that mental health policy advocacy is likely to be most effective when it involves personal stories about mental illness.

The finding that legislators who prioritized BH issues significantly preferred research delivered by a known and trusted individual suggests potential for initiatives that foster relationships between BH researchers and legislators. An initiative to enhance collaboration between mental health researchers and policy makers in Canada offers a model (47). BH researchers might also establish relationships with, and disseminate research findings directly to, legislative research bureau staff, given that these staff were identified as legislators’ primary source for research evidence.

Our study can inform how BH researchers might utilize the media to infuse research evidence into policy-making processes. Scholars have asserted that the media play a major role in shaping BH policy (48,49). We found, however, that legislators rated the media as the least reliable and least utilized source for research. It is possible that BH research influences policy making indirectly via legislators’ constituents, who become knowledgeable about BH research through the media and advocate for legislators to act on this research. As noted, constituent needs and opinions were identified as the most influential factors determining health policy priorities, and constituents were perceived as the second most reliable source of research.

We did not observe significant differences in political ideology between legislators who did and did not prioritize BH issues. This suggests bipartisan support for BH policies, a situation that would increase the chances of BH policy proposals’ becoming law. However, our study did not explore legislators’ opinions about the types of policy approaches that should be used to address BH issues or the extent to which they were evidence based or varied by political ideology. As Corrigan and colleagues (50) described, conservative and liberal legislators are likely to consider decisions to allocate resources for mental health services differently, with liberals being more inclined to support government funding of services.

Limitations of this study derive from the fact that we conducted a secondary analysis of an existing data set. Measures assessed legislators’ preferences and practices related to research evidence in general, not BH research in particular. This limits what can be inferred from the study. For example, we observed a strong association between identification of research evidence as a factor that determined health policy priorities and legislator prioritization of BH issues, but we cannot infer that BH research evidence contributed to legislators’ determination that BH issues were a priority.

There are also limitations with our broad measure of BH issue prioritization. Legislators identified a range of specific BH issues (for example, depression among elderly people and prescription drug abuse among adolescents) in open-ended responses, but we combined these issues into a single measure because we did not have statistical power to conduct subissue analyses. Although many BH conditions are comorbid and simultaneously addressed by a single law (for example, state BH parity legislation), they affect distinct populations with specific needs. Future research should explore the particular types of research used by legislators when they are working on specific BH issues.

There are similar limitations with our measure of non–BH issue prioritization. Legislators in this group identified a various issues as policy priorities in response to Q1, some of which are not the subject of extensive research (for example, unemployment and transportation). Consequently, compared with legislators who prioritized BH issues, legislators who did not may have reported engaging in research-seeking and utilization practices less frequently because they were focused on issues for which research evidence is less relevant. This is unlikely to affect the implications of our study, however, because it simply signals that legislators who prioritize BH issues may engage in different research-seeking practices than legislators who do not prioritize these issues and that tailored dissemination strategies may be warranted. Our study was designed to assess whether use of research practices differed between legislators who did and did not prioritize BH issues, not to determine the reasons for the differences observed.

Conclusions

Compared with legislators who did not prioritize BH issues, legislators who prioritized BH issues more actively sought, had distinct preferences for, and were more influenced by research evidence. These results suggest potential for BH research findings to inform legislative decisions. Developing and testing policy-focused BH research dissemination strategies are areas for future research that can advance evidence-based policies to improve the well-being of people affected by BH issues.

Dr. Purtle is with the Department of Health Management and Policy, Drexel University, Philadelphia (e-mail: ). Dr. Dodson is with the Institute for Public Health, and Dr. Brownson is with the Division of Public Health Sciences and Siteman Cancer Center, Washington University in St. Louis.

This research was presented at the AcademyHealth Annual Dissemination and Implementation Conference, Washington, D.C., December 14–15, 2015.

This research was funded in part by grant 1R01CA124404-01 from the National Cancer Institute, grant 1P30DK092950 from the National Institute of Diabetes and Digestive and Kidney Diseases, grant UL1 TR000448 from the Washington University Institute of Clinical and Translational Sciences, and grant KL2 TR000450 from the National Center for Advancing Translational Sciences.

The authors report no financial relationships with commercial interests.

References

1 Mechanic D: Policy challenges in improving mental health services: some lessons from the past. Psychiatric Services 54:1227–1232, 2003LinkGoogle Scholar

2 Tanenbaum SJ: Evidence-based practice as mental health policy: three controversies and a caveat. Health Affairs 24:163–173, 2005CrossrefGoogle Scholar

3 Lehman AF, Goldman H, Dixon LB, et al: Evidence-Based Mental Health Treatments and Services: Examples to Inform Public Policy. New York, Milbank Memorial Fund, 2004. http://www.milbank.org/uploads/documents/2004lehman/2004lehman.htmlGoogle Scholar

4 Hogan M: Using evidence to influence policy and improve practice. Psychiatric Services 66:769, 2015LinkGoogle Scholar

5 Nelson G: Community psychology and transformative policy change in the neo-liberal era. American Journal of Community Psychology 52:211–223, 2013Crossref, MedlineGoogle Scholar

6 Sarason SB: Community psychology and public policy: missed opportunity. American Journal of Community Psychology 12:199–207, 1984Crossref, MedlineGoogle Scholar

7 Shaping and Informing Public Policy to Improve Lives. Rockville, Md, Substance Abuse and Mental Health Services Administration, 2011. http://store.samhsa.gov/product/Shaping-and-Informing-Public-Policy-to-Improve-Lives/SMA11-PHYDE042611Google Scholar

8 Strategic Plan for Research. Bethesda, Md, National Institute of Mental Health, 2015. http://www.nimh.nih.gov/about/strategic-planning-reports/NIMH_StrategicPlanforResearch_508Compliant_CORRECTED_FINAL_149979.pdfGoogle Scholar

9 Strategic Plan. Bethesda, Md, National Institute on Drug Abuse, 2010. https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/stratplan.pdfGoogle Scholar

10 Mission Statement. Bethesda, Md, National Institute on Alcohol Abuse and Alcoholism. http://www.niaaa.nih.gov/about-niaaa/our-work/mission-statementGoogle Scholar

11 Rabin BA, Brownson RC, Haire-Joshu D, et al.: A glossary for dissemination and implementation research in health. Journal of Public Health Management and Practice 14:117–123, 2008Crossref, MedlineGoogle Scholar

12 Glasgow RE, Vinson C, Chambers D, et al.: National Institutes of Health approaches to dissemination and implementation science: current and future directions. American Journal of Public Health 102:1274–1281, 2012Crossref, MedlineGoogle Scholar

13 Brownson RC, Jacobs JA, Tabak RG, et al.: Designing for dissemination among public health researchers: findings from a national survey in the United States. American Journal of Public Health 103:1693–1699, 2013Crossref, MedlineGoogle Scholar

14 Bero LA, Grilli R, Grimshaw JM, et al.: Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 317:465–468, 1998Crossref, MedlineGoogle Scholar

15 Brownson RC, Royer C, Ewing R, et al.: Researchers and policymakers: travelers in parallel universes. American Journal of Preventive Medicine 30:164–172, 2006Crossref, MedlineGoogle Scholar

16 Bogenschneider K, Corbett TJ: Evidence-Based Policymaking: Insights From Policy-Minded Researchers and Research-Minded Policymakers. New York, Routledge, 2011CrossrefGoogle Scholar

17 Lomas J: Diffusion, dissemination, and implementation: who should do what? Annals of the New York Academy of Sciences 703:226–235, 1993Crossref, MedlineGoogle Scholar

18 Dodson E, Brownson RC, Weiss S: Policy dissemination research; in Dissemination and Implementation Research in Health: Translating Science to Practice. Edited by Brownson RC, Colditz GA, Proctor EK. Oxford, United Kingdom, Oxford University Press, 2012CrossrefGoogle Scholar

19 Glasgow RE, Chambers DA, Cynkin L: News from the NIH: highlights in implementation science from the National Cancer Institute and the National Institute of Mental Health. Translational Behavioral Medicine 3:335–337, 2013Crossref, MedlineGoogle Scholar

20 Brownson RC, Seiler R, Eyler AA: Measuring the impact of public health policy. Preventing Chronic Disease 7:A77, 2010MedlineGoogle Scholar

21 Purtle J, Peters R, Brownson R: A review of policy dissemination and implementation research funded by the National Institutes of Health, 2007–2014. Implementation Science (Epub ahead of print, Jan 4, 2016)MedlineGoogle Scholar

22 Williamson A, Makkar SR, McGrath C, et al.: How can the use of evidence in mental health policy be increased? A systematic review. Psychiatric Services 66:783–797, 2015LinkGoogle Scholar

23 Oliver K, Innvar S, Lorenc T, et al.: A systematic review of barriers to and facilitators of the use of evidence by policymakers. BMC Health Services Research 14:2, 2014Crossref, MedlineGoogle Scholar

24 Goldner EM, Jeffries V, Bilsker D, et al.: Knowledge translation in mental health: a scoping review. Healthcare Policy 7:83–98, 2011MedlineGoogle Scholar

25 Waddell C, Lavis JN, Abelson J, et al.: Research use in children’s mental health policy in Canada: maintaining vigilance amid ambiguity. Social Science and Medicine 61:1649–1657, 2005Crossref, MedlineGoogle Scholar

26 Waddell C, Shepherd CA, Lavis JN, et al.: Balancing rigour and relevance: researchers’ contributions to children’s mental health in Canada. Evidence and Policy 3:181–195, 2007CrossrefGoogle Scholar

27 Ritter A: The role of research evidence in drug policy development in Australia. Politička Misao 48:141–156, 2012Google Scholar

28 Ritter A, Lancaster K: Measuring research influence on drug policy: a case example of two epidemiological monitoring systems. International Journal on Drug Policy 24:30–37, 2013Crossref, MedlineGoogle Scholar

29 Tieberghien J, Decorte T: Understanding the science–policy nexus in Belgium: an analysis of the drug policy debate (1996–2003). Drugs Education: Prevention and Policy 20:241–248, 2013CrossrefGoogle Scholar

30 Corrigan PW, Watson AC: Factors that explain how policy makers distribute resources to mental health services. Psychiatric Services 54:501–507, 2003LinkGoogle Scholar

31 Barry CL, Huskamp HA, Goldman HH: A political history of federal mental health and addiction insurance parity. Milbank Quarterly 88:404–433, 2010Crossref, MedlineGoogle Scholar

32 Cummings JR, Wen H, Ko M, et al.: Geography and the Medicaid mental health care infrastructure: implications for health care reform. JAMA Psychiatry 70:1084–1090, 2013Crossref, MedlineGoogle Scholar

33 Mark T, Levit K, Coffey R: National Expenditures for Mental Health Services and Substance Abuse Treatment, 1993–2003. Pub no SMA 07-4227. Rockville, Md, Substance Abuse and Mental Health Services Administration, 2008Google Scholar

34 Hernandez EM, Uggen C: Institutions, politics, and mental health parity. Society and Mental Health 2:154–171, 2012CrossrefGoogle Scholar

35 Burns ME: State discretion over Medicaid coverage for mental health and addiction services. Psychiatric Services 66:221–223, 2015LinkGoogle Scholar

36 Wen H, Cummings JR, Hockenberry JM, et al.: State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislation. JAMA Psychiatry 70:1355–1362, 2013Crossref, MedlineGoogle Scholar

37 Kingdon JW: Agendas, Alternatives, and Public Policies. New York, Little, Brown, 1984Google Scholar

38 Sabatier PA, Weible C (ed): Theories of the Policy Process. Boulder, Colo, Westview Press, 2014Google Scholar

39 Mintrom M, Norman P: Policy entrepreneurship and policy change. Policy Studies Journal 37:649–667, 2009CrossrefGoogle Scholar

40 Brownson RC, Dodson EA, Stamatakis KA, et al.: Communicating evidence-based information on cancer prevention to state-level policy makers. Journal of the National Cancer Institute 103:306–316, 2011Crossref, MedlineGoogle Scholar

41 Bogenschneider K, Little OM, Johnson K: Policymakers’ use of social science research: looking within and across policy actors. Journal of Marriage and the Family 75:263–275, 2013CrossrefGoogle Scholar

42 Moreland-Russell S, Barbero C, Andersen S, et al.: “Hearing from all sides”: how legislative testimony influences state level policy-makers in the United States. International Journal of Health Policy and Management 4:91–98, 2015Crossref, MedlineGoogle Scholar

43 Stamatakis KA, McBride TD, Brownson RC: Communicating prevention messages to policy makers: the role of stories in promoting physical activity. Journal of Physical Activity and Health 7(suppl 1):S99–S107, 2010Crossref, MedlineGoogle Scholar

44 Baesler EJ, Burgoon JK: The temporal effects of story and statistical evidence on belief change. Communication Research 21:582–602, 1994CrossrefGoogle Scholar

45 Kreuter MW, Green MC, Cappella JN, et al.: Narrative communication in cancer prevention and control: a framework to guide research and application. Annals of Behavioral Medicine 33:221–235, 2007Crossref, MedlineGoogle Scholar

46 Stuber JP, Rocha A, Christian A, et al.: Conceptions of mental illness: attitudes of mental health professionals and the general public. Psychiatric Services 65:490–497, 2014LinkGoogle Scholar

47 Goering P, Butterill D, Jacobson N, et al.: Linkage and exchange at the organizational level: a model of collaboration between research and policy. Journal of Health Services Research & Policy 8(suppl 2):14–19, 2003Crossref, MedlineGoogle Scholar

48 Wahl OF: News media portrayal of mental illness implications for public policy. American Behavioral Scientist 46:1594–1600, 2003CrossrefGoogle Scholar

49 Hallam A: Media influences on mental health policy: long-term effects of the Clunis and Silcock cases. International Review of Psychiatry 14:26–33, 2002CrossrefGoogle Scholar

50 Corrigan PW, Watson AC, Warpinski AC, et al.: Stigmatizing attitudes about mental illness and allocation of resources to mental health services. Community Mental Health Journal 40:297–307, 2004Crossref, MedlineGoogle Scholar